Lisa Shuchman
Lisa Shuchman is Executive Editor of Law.com International. At ALM she has also worked for The American Lawyer and Corporate Counsel. Prior to joining ALM, she worked in Japan for The Wall Street Journal and The New York Times, and in the U.S. for the Associated Press, The Industry Standard, and regional newspapers. She received a B.A. from Wesleyan University and an M.S. from Columbia University's Graduate School of Journalism. Contact her at [email protected]. On Twitter: @LisaLawReporter.
November 02, 2015 | Texas Lawyer
Patent Litigation Will Never Be the Same AgainPatent litigation isn't what it used to be. Monumental changes to U.S. patent law have changed the rules of the litigation game.
By Lisa Shuchman
9 minute read
November 01, 2015 | The American Lawyer
IP Litigation Spotlight: Changing the RulesNew legislation, new regulator, new decisions: Change is the one constant in the IP scrum.
By Lisa Shuchman
9 minute read
November 01, 2015 | The American Lawyer
IP Litigation Spotlight: Changing the RulesNew legislation, new regulator, new decisions: Change is the one constant in the IP scrum.
By Lisa Shuchman
9 minute read
October 29, 2015 | Texas Lawyer
Patent Litigation Will Never Be the Same AgainPatent litigation isn't what it used to be. Monumental changes to U.S. patent law have changed the rules of the litigation game.
By Lisa Shuchman
9 minute read
October 28, 2015 | Law.com
Kyle Bass, the Man Big Pharma Loves to Hate, Wins a RoundKyle Bass, the hedge fund manager vilified by the pharmaceutical industry and much of the patent bar, just gave his detractors more reason to resent him. The U.S. Patent and Trademark Office has agreed within the last week to institute trials for six of the drug patents Bass has challenged.
By Lisa Shuchman
4 minute read
October 28, 2015 | Law.com
Trolls Begone (for Now): Patent Pleading Rules Get TougherForm 18 was eliminated when federal civil rules were revised. Now nonpracticing entities won't be able to cut and paste complaints against multiple defendants.
By Lisa Shuchman
5 minute read
October 28, 2015 | Corporate Counsel
Kyle Bass, the Man Big Pharma Loves to Hate, Wins a RoundKyle Bass, the hedge fund manager vilified by the pharmaceutical industry and much of the patent bar, just gave his detractors more reason to resent him. The U.S. Patent and Trademark Office has agreed within the last week to institute trials for six of the drug patents Bass has challenged.
By Lisa Shuchman
4 minute read
October 28, 2015 | Corporate Counsel
Trolls Begone (for Now): Patent Pleading Rules Get TougherForm 18 was eliminated when federal civil rules were revised. Now nonpracticing entities won't be able to cut and paste complaints against multiple defendants.
By Lisa Shuchman
5 minute read
October 26, 2015 | Law.com
Patent Litigation Will Never Be the Same AgainThe practice has been changed forever. A lot of lawyers preferred the old way.
By Lisa Shuchman
9 minute read
October 25, 2015 | Corporate Counsel
Patent Litigation Will Never Be the Same AgainThe practice has been changed forever. A lot of lawyers preferred the old way.
By Lisa Shuchman
9 minute read
Trending Stories
- 1Supreme Court Takes Up Challenge to ACA Task Force
- 2'Tragedy of Unspeakable Proportions:' Could Edison, DWP, Face Lawsuits Over LA Wildfires?
- 3Meta Pulls Plug on DEI Programs
- 4On the Move and After Hours: Meyner and Landis; Cooper Levenson; Ogletree Deakins; Saiber
- 5State Budget Proposal Includes More Money for Courts—for Now
More from ALM
- Scan In Progress: Litigators Leverage AI to Screen Prospective Jurors 1 minute read
- Legal Speak at General Counsel Conference East 2024: Match Group's Katie Dugan & Herrick's Carol Goodman 1 minute read
- Legal Speak at General Counsel Conference East 2024: Eric Wall, Executive VP, Syllo 1 minute read